Sartorius | SRT3 - Le Bénéfice D'Exploitation

Prix De L'Action
216.80
Variation Quotidienne
2.40 1.12%
Mensuellement
0.84%
Annuel
13.96%
Q2 Prévisions
206.18




Le Bénéfice D'Exploitation Changement Date
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Avita Medical AUD -10.41M 742K 2025-12
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Moderna USD -857M 597M 2025-12
Organon & Co USD 388M 62M 2025-09
Revvity USD 145.83M 47.49M 2025-12
Sartorius EUR 150.1M 11.7M 2025-09
Tectonic Therapeutic USD -21.52M 374K 2025-12
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 16.77M 10.04M 2025-12